StairMed: RMB 500 Million (About $69 Million) Raised For Brain Machine Interface Development
By Amit Chowdhry ● Today at 11:20 AM
Shanghai-based StairMed has secured RMB 500 million in a new financing round led by Alibaba, with participation from existing investors including Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed, Qiming Venture Partners, Lilly Asia Ventures, and Source Code Capital. The latest raise brings the company’s total funding over the past year to more than RMB 1.1 billion and represents a rare joint investment by Alibaba and Tencent in the brain-machine interface sector.